How much funding has Treeline Biosciences raised?

Treeline Biosciences has raised $821.8M in total funding, most recently a Extension Round.

Who are Treeline Biosciences's investors?

Treeline Biosciences's investors include The GBA Fund, GV (Google Ventures), HM Capital, RiverVest Venture, Lightchain Capital, Abingworth Bioventures.

When was Treeline Biosciences founded?

Treeline Biosciences was founded in 2021.

Where is Treeline Biosciences headquartered?

Treeline Biosciences is headquartered in Watertown, Massachusetts, United States.

What industry is Treeline Biosciences in?

Treeline Biosciences operates in Biotech, Drug Discovery, Life Sciences.

How many employees does Treeline Biosciences have?

Treeline Biosciences has 51-200 employees.

Treeline Biosciences

Medicines, elevated

Watertown, United States · Founded 2021 · $821.8M raised

Biotech

Drug Discovery

Life Sciences

Headquarters: Watertown, Massachusetts
Employees: 51–200
Founded: 2021
Business Model: B2B

Website: treeline.bio
Total Funding: $821.8M
Last Round: $200.0M Extension RoundSep 2025
Rounds: 3

About

Treeline Biosciences is a clinical-stage biopharma developing precision medicines for cancer, autoimmune, and neurological diseases. The company integrates in-house biology, chemistry, protein science, and computational/ML tools to advance a pipeline of inhibitors, protein degraders, and antibody drug conjugates through human clinical trials.

Summary

Treeline Biosciences is a Biotech company based in Watertown, United States, founded in 2021. It has raised $821.8M in total across 3 rounds, most recently a $200.0M Extension Round round in Sep 2025. Investors include The GBA Fund, GV (Google Ventures) and HM Capital.

LinkedIn X (Twitter)